Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma

NCT02202564 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer
Hepatocellular Carcinoma

Interventions

PROCEDURE: LT
DRUG: ADV-TK
DRUG: ganciclovir

Sponsor

Huazhong University of Science and Technology

Collaborators

[object Object]